QCM
ORIC icon

Quantinno Capital Management’s Oric Pharmaceuticals ORIC Stock Holding History

Quantinno Capital Management’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$235K Sell
21,689
-3,837
-15% -$34.8K ﹤0.01% 3297
2026
Q1 		$323K Buy
25,526
+2,170
+9% +$24.6K ﹤0.01% 2990
2025
Q4 		$191K Buy
23,356
+11,093
+90% +$128K ﹤0.01% 3062
2025
Q3 		$147K Buy
+12,263
New +$129K ﹤0.01% 2836

Other funds holding ORIC

NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Quantinno Capital Management's ORIC Position: Q2 2026 in Review

Quantinno Capital Management reduced its Oric Pharmaceuticals (ORIC) stake by 15% in Q2 2026, selling an estimated $34.8K and leaving 21,689 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #3297.

Quantinno Capital Management first reported a position in ORIC in Q3 2025 and has held it in 4 quarters since. The position peaked at $323K in Q1 2026. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

  • Quantinno Capital Management held 21,689 shares of Oric Pharmaceuticals worth $235K as of Q2 2026.
  • Quantinno Capital Management sold 3,837 Oric Pharmaceuticals shares in Q2 2026, an estimated $34.8K.
  • Oric Pharmaceuticals made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #3297 holding.
  • Quantinno Capital Management first reported a position in Oric Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Quantinno Capital Management's Oric Pharmaceuticals position peaked at $323K in Q1 2026.
  • 180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.